Osang Zaiel, Up 5.24% on Rising Theme of COVID-19 (Diagnosis/Treatment/Vaccine Development, etc.)

Published 14 May.2020 10:45(KST)

On the 14th, the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme rose 3.62% compared to the previous day, showing strength, while Osangjaiel, a related stock attracting attention, surged 5.24% compared to the previous day. Osangjaiel is known as a company developing integrated information systems and supplying fruit packaging materials.

[Graph] Major stock price changes in the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme

According to provisional data compiled at 10:17 AM, foreigners are net selling -9,000 shares of Osangjaiel.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Osangjaiel’s quant financial score is 6.63 points, which is lower in stability, profitability, and growth scores compared to the average of other stocks related to COVID-19 (diagnosis/treatment/vaccine development, etc.). This can be interpreted as Osangjaiel having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, United Pharmaceutical ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top financial scores within the theme

※ The quant financial score is the result of analysis by the robo algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.